Hospital for Special Surgery · 17 hours ago
POSTDOCTORAL ASSOCIATE
New York, NY
Full-time
Onsite
New Grad, Entry Level
$69K/yr - $69K/yrHospital for Special Surgery is a top-ranked hospital for orthopedics and rheumatology, seeking a highly motivated Postdoctoral Associate to join their research team. The role involves investigating the molecular drivers of human autoimmunity using advanced genomic sequencing technologies and cellular mechanistic assays.
Health CareMedical
Responsibilities
Identifying genomic drivers in human immune disorders
Investigate the role of somatic mutations in the pathogenesis and progression of autoimmune disease
Qualification
Required
Hold a PhD, MD/PhD, or equivalent degree in Immunology, Molecular Biology, Genomics, or a related field
Demonstrated expertise in one or more of the following areas: Molecular biology and genome-wide sequencing approaches
Demonstrated expertise in one or more of the following areas: Flow cytometry and primary immune cell culture assays
Benefits
$6000/year in housing supplement
Company
Hospital for Special Surgery
Hospital for special surgery is the top ranked new york hospital for orthopedics and rheumatology.
Founded in 1863
5001-10000 employees
H1B Sponsorship
Hospital for Special Surgery has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (26)
2024 (20)
2023 (27)
2022 (32)
2021 (18)
2020 (27)
Funding
Current Stage
Late StageTotal Funding
$36.6MKey Investors
Stavros Niarchos Foundation (SNF)Flare Capital Partners
2023-06-12Grant· $10M
2022-10-25Series A· $21M
2018-07-16Grant· $5.6M
Leadership Team
Tara M. McCoy
Chief Executive Officer, HSS Florida
Bill Donato
Senior Advisor Supply Chain
Recent News
Crain's New York Business
2026-01-13
HospitalManagement.net
2026-01-13
Company data provided by crunchbase